rs121912653
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs121912655
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.
|
27276934 |
2017 |
rs121912657
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs121913344
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations.
|
27726232 |
2017 |
rs267605076
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Synonymous mutation in TP53 results in a cryptic splice site affecting its DNA-binding site in an adolescent with two primary sarcomas.
|
28475293 |
2017 |
rs28934873
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs587780075
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs730882018
|
|
CG |
0.700 |
CausalMutation |
CLINVAR |
Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.
|
28369373 |
2017 |
rs876660821
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.
|
28724667 |
2017 |
rs1057519989
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Genetic and functional analysis of a Li Fraumeni syndrome family in China.
|
26818906 |
2016 |
rs1131691026
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.
|
27328919 |
2016 |
rs1131691026
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
|
27501770 |
2016 |
rs11575997
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
|
27501770 |
2016 |
rs17882252
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
|
26641009 |
2016 |
rs397516434
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
|
27496084 |
2016 |
rs397516434
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
|
27501770 |
2016 |
rs397516435
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
|
27501770 |
2016 |
rs397516435
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
|
26787237 |
2016 |
rs55863639
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
|
27501770 |
2016 |
rs587780074
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
|
26534844 |
2016 |
rs730882001
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
|
26681312 |
2016 |
rs730882029
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India.
|
26911350 |
2016 |
rs730882029
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Complex analysis of the p53 tumor suppressor in lung carcinoma.
|
26718964 |
2016 |
rs760043106
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
|
26534844 |
2016 |
rs786201057
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Improving performance of multigene panels for genomic analysis of cancer predisposition.
|
26845104 |
2016 |